Table 6.

Biorepository

Biologic	Sample #	Sample details	Potential ancillary analyses on stored (frozen) samples†
Bone marrow	n=144 (all patients)	Fresh BM, flash frozen buffy coat, cryopreserved buffy coat, cryopreserved BM supernatant	In vivo and in vitro studies, RNA, DNA, protein
BM-MNCs	n=72, (placebo & CPC patients)	Cryopreserved MNCs	In vivo and in vitro studies, RNA, DNA, protein
Excess cell product	n=144 (3 active groups)*	10-30 million MSCs, 0.5-1 million CPCs	In vivo and in vitro studies, RNA, DNA, protein
Cell culture medium	n=144, (3 active groups)*	up to 10 12-ml aliquots	Secretome (microparticles/ exosomes, miRNAs, cyto/chemokines, GFs)
Peripheral Blood	n=144 (all patients)	Flash frozen buffy coat and plasma, cryopreserved buffy coat and plasma	In vivo and in vitro studies, RNA, DNA, protein, secretome (microparticles/ exosomes, miRNAs, cyto/chemokines, GFs)
Explanted Heart (as available)	Unknown	10 cardiac regions, formalin fixed or flash frozen	RNA, DNA, protein, histology,

^*One product/MSC patient, 1 product/CPC patient; 2 products/MSC + CPC patient

^†Analyses require ancillary study application and funding source outside scope; samples are stored in such a way as to realize these potential future analyses